← Eichor
Study identifier: NCT04964765 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Basel CardioInsightTM - 3D Mapping Study

Condition: New-onset Atrial Fibrillation (NOAF)  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseN/A
Planned participants157
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is to describe the exact location of NOAF-maintaining foci and rotors after cardiac surgery identified by mapping using the non-invasive phase mapping with CardioInsightTM - 3D Mapping technology (CardioInsightTM, Medtronic Switzerland, Tolochenaz, Switzerland) and a low-dose computed tomography scan of the chest.

This description comes directly from the study's public registry record.

Talk to the study team

David Santer, Dr. med.  ·  +41 61 32 85818  ·  david.santer@usb.ch

Always discuss trial participation with your own doctor first.

Locations (2)

University Hospital St. PöltenSankt Pölten, AustriaRecruiting
Department of Cardiac Surgery, University Hospital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04964765